Prof. Dr. Geerd Weyer had extensive academic and industry experience when he founded ICRC-Weyer in 1993. Drawing back on his core expertise in research methodology, including psychometrics and statistics, he started out with consulting services to support clients from the pharmaceutical industry in their clinical study projects. Expanding from this basis, Prof. Weyer developed a team of clinical research professionals who provide a broad range of services in the domains of clinical and medical data management, biometrics, medical writing and pharmacovigilance. Under his lead, the company’s business grew continuously over the years and in 2010 the firm was incorporated as the limited liability company “ICRC-Weyer GmbH”.
As Managing Director, Prof. Weyer leads and supervises the company’s operations and as scientific consultant he provides advice and support for clinical research activities. Since 2011, he shares responsibilities for the management of the company with his son Johann Daniel who became the second Managing Director.
Prof. Weyer acted as referee for the re-accreditation of the MSc program “Clinical Trial Management” at the Beuth University of Applied Sciences, Berlin and supervises bachelor theses at the PAREXEL Academic Institute/Medical School, Berlin. He is the author of the German version of the Alzheimer’s Disease Assessment Scale (ADAS) and the well-known CIPS compendium of psychiatric rating scales (5th and 6th edition).